http://www.amicusrx.com
Amicus Therapeutics, Inc. Company Intro
Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases.
Industry
Healthcare
Amicus Therapeutics, Inc. Headquaters
1 Cedar Brook Drive
Cranbury,08512
United States
Amicus Therapeutics, Inc. Share price
14 Sep 2022 09:15 GMT
$11.12
-0.22 (-1.94 %)
Amicus Therapeutics, Inc. Market cap
$2.94 B
WMC RANKING
2022
Amicus Therapeutics, Inc. # 39
BiotechnologyLatest Amicus Therapeutics, Inc. News
26 Sep 2022
Fabry Disease Treatment Market to surpass USD 3.5 billion by ...
Rising emphasis on the advancement of genetic disease therapies will drive ... Sanofi, Amicus Therapeutics, ISU Abaxis, and JCR Pharmaceuticals Co Ltd,...
26 Sep 2022
Is Amicus Therapeutics Inc. (NASDAQ: FOLD) Still On The Rise?
After-hours trades for Amicus Therapeutics Inc. (FOLD) shows that investor sentiment remained broken, with the stock's consolidated last price falling by...
26 Sep 2022
Fabry Disease Treatment Market to surpass USD 3.5 billion by ...
Rising emphasis on the advancement of genetic disease therapies will drive ... Sanofi, Amicus Therapeutics, ISU Abaxis, and JCR Pharmaceuticals Co Ltd,...
WMC Market Score
WMC Market to Revenue Score
Amicus Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Amicus Therapeutics, Inc. | USD | $266,763 | $455,044 | $-253,568 | $29,400B | 39 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Amicus Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Amicus Therapeutics, Inc. Post vs Top 4 Industry Competitors
Amicus Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Amicus Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Amicus Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Amicus Therapeutics, Inc. | 4.26 | 13.30 | 0.04 | 0 | 0 | 0 | 4.45 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 100 | 0 | 0 | 100 |
| Incyte Corporation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
